Why the study?
Does intravenous magnesium prevent postoperative atrial fibrillation in patients undergoing coronary artery bypass surgery?
Does intravenous magnesium prevent postoperative atrial fibrillation in patients undergoing coronary artery bypass surgery?
Prophylactic intravenous magnesium significantly reduces the risk of developing atrial fibrillation after coronary artery bypass surgery.
Answers are grounded in this paper and cite their sources.
Supports prophylactic IV magnesium in CABG; reinforces randomized evidence for POAF prevention.
Atrial fibrillation (AF) is one of the most common complications after coronary artery bypass surgery. The objective of this study was to assess the effectiveness of intravenous magnesium in preventing postoperative atrial fibrillation. A meta-analysis of eight identified randomized controlled trials, reporting comparisons between magnesium and control was undertaken. The primary outcome was incidence of postoperative atrial fibrillation. Our review revealed that use of intravenous magnesium is associated with a significant reduction in the incidence of atrial fibrillation after coronary artery bypass surgery, with a relative risk of 0.64 (95% confidence interval = 0.47, 0.87, and p = 0.004).
No takes yet. Share an insight, caveat, or question.
Alghamdi et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: